Optogenetics
Showing 1 - 7 of 7
EyeConic: Qualification for Cone-Optogenetics
Recruiting
- Retinal Dystrophies
- OCT
-
San Francisco, California
- +8 more
Nov 1, 2022
Qualification for Cone-Optogenetics
Recruiting
- Retinal Dystrophies
- OCT
-
San Francisco, California
- +8 more
Jan 19, 2022
Study in Subjects Who Received vMCO-I Administered Via
Enrolling by invitation
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023
Advanced Retinitis Pigmentosa Trial in United States (RST-001)
Active, not recruiting
- Advanced Retinitis Pigmentosa
-
San Francisco, California
- +3 more
Sep 9, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Retinitis Pigmentosa, Retinal Diseases, Retinal Degeneration Trial in Cuttack (Gene Therapy product:vMCO-I)
Completed
- Retinitis Pigmentosa
- +2 more
- Gene Therapy product:vMCO-I
-
Cuttack, Odisha, IndiaJPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 2, 2021
Anxiety Disorders, Anxiety, Anxiety and Fear Trial in Bordeaux (behavioral, other, diagnostic test)
Unknown status
- Anxiety Disorders
- +2 more
- In vivo social exposure
- +4 more
-
Bordeaux, FranceGENPHASS, SANPSY, CHU de Bordeaux
Nov 22, 2019